Table 1.
Clinical characteristics of patients.
| Anti-NMDAR encephalitis | Encephalitis of other causes | Peripheral neuropathy | |
|---|---|---|---|
| Number of patients (n) | 24 | 13 | 11 |
| Gender (female/male) | 14/10 | 8/5 | 5/6 |
| Age (years) | 39.58 ± 17.51 | 39 ± 18.93 | 45.64 ± 13.82 |
| Number of symptoms (n) | |||
| Prodromal symptoms (headache, fever) | 11 | 4 | 0 |
| Disorders of memory, behavior, and cognition | 23 | 3 | 1 |
| Seizures | 11 | 1 | 0 |
| Autonomic symptoms | 13 | 2 | 1 |
| Loss of consciousness | 15 | 4 | 0 |
| Movement disorder | 14 | 7 | 9 |
| Ovarian teratoma | 3 | 0 | 0 |
| Maximum mRS | 3.75 ± 0.79 | 2.92 ± 1.55 | |
| 6 months' mRS | 2.38 ± 0.97 | 1.85 ± 1.21 | |
| CSF anti-NMDAR antibody | 24 | 0 | 0 |
| Serum anti-NMDAR antibody | 18 | 0 | 0 |